Mirae Asset Global ETFs Holdings
MAZE

Mirae Asset Global ETFs Holdings’s Maze Therapeutics MAZE Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$371K Sell
12,416
-18,879
-60% -$833K ﹤0.01% 2042
2025
Q4 		$1.3M Buy
31,295
+22,217
+245% +$764K ﹤0.01% 1377
2025
Q3 		$235K Buy
9,078
+4,177
+85% +$70.5K ﹤0.01% 2247
2025
Q2 		$60.1K Sell
4,901
-234
-5% -$2.43K ﹤0.01% 2838
2025
Q1 		$56.5K Buy
+5,135
New +$61.8K ﹤0.01% 2825

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mirae Asset Global ETFs Holdings's MAZE Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Maze Therapeutics (MAZE) stake by 60% in Q1 2026, selling an estimated $833K and leaving 12,416 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

Mirae Asset Global ETFs Holdings first reported a position in MAZE in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.3M in Q4 2025. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 12,416 shares of Maze Therapeutics worth $371K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 18,879 Maze Therapeutics shares in Q1 2026, an estimated $833K.
  • Maze Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2042 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Maze Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Maze Therapeutics position peaked at $1.3M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.